Thanks a lot Claus.

I'm working in a new guideline into a multiprofesional group of the Iberoamerican Cochrane Centre.

Kind regards

Lola

I'm working on a new project on the relationship between glycemic load, glycemic index and cardiometabolic risk during menopause.

I use less Guidelines from the Spanish Association for the Study of Menopause

Hello Khedidja, sorry I haven't seen your answer until now. Your project sounds really interesting.

Thank you for your answer José. we're just updating the one you mentioned above because it's obsolete.

Kind regards.

Lola

Cardiovascular outcomes should be taken into consideration, so as for the guidelines we use:

6. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update / L. Mosca [et аl.] // Circulation. – 2007. – Vol. 115. – Р. 1481-1501.

7. Evidence-based guidelines for cardiovascular disease prevention in women / Mosca L., Appel L.J., Benjamin E.J. [et al.] // Circulation. – 2004. – Vol. 109. – P. 672-693.

But also I would suggest following references worth mentioning with an insight on cardiovascular system:

1. Bello N. Epidemiology of coronary heart disease in women / N. Bello, L. Mosca // Prog Cardiovasc Dis. – 2004. – Vol. 46. – Р.287-295.

2. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial / Anderson G.L., Limacher M., Assaf A.R. [et al.] // JAMA. – 2004. – Vol. 291. – P.1701-1712.

3. Elevated arterial stiffness in postmenopausal women with osteoporosis / H. Sumino, S. Ichikawa, S. Kasama [et al.] // Maturitas. – 2006. – Vol. 55. – Р. 212–218.

4. Eric Levens. Current opinions and understandings of menopausal women about hormone replacement therapy (HRT) — The University of Florida experience / Levens Eric, R. Stan Williams // American Journal of Obstetrics and Gynecology. – 2004. – Vol. 191, № 2. – Р. 641-646.

5. Estrogen plus progestin and the risk of coronary heart disease / Manson J.E., Hsia J., Johnson K.C. [et al.] // N Engl J Med. – 2003. – Vol. 349. – P. 523-534.

6. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update / L. Mosca [et аl.] // Circulation. – 2007. – Vol. 115. – Р. 1481-1501.

7. Evidence-based guidelines for cardiovascular disease prevention in women / Mosca L., Appel L.J., Benjamin E.J. [et al.] // Circulation. – 2004. – Vol. 109. – P. 672-693.

8. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases / N. Jochmann, K. Stangl, E. Garbe [et al.] // Eur Heart J. – 2005. – Vol. 26, №16. – P. 1585-1595.

9. Gender differences in recovery after coronary artery bypass surgery / Vaccarino V., Lin Z.Q., Kasl S.V. [et al.] // J Am Coll Cardiol. – 2003. Vol. 41 – P. 307-314.

10. Gender-related effects on metoprolol pharmacokinetics and pharmaco-dynamics in healthy volunteers / A.B. Luzier, A. Killian, J.H. Wilton, M.F. Wilson // Clin Pharmacol Ther. – 1999. – Vol. 66. – P. 594-601.

11. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association / Mosca L., Collins P., Herrington D.M. [et al.] // Circulation. – 2001. – Vol. 104. – P. 499–503.

12. Hyperhomocysteinemia in menopausal hypertension: an added risk factor and a dangerous association for organ damage / R. Noto, S. Neri, G. Molino [et al.] // Eur Rev Med Pharmacol Sci. – 2002. – Vol. 6, №4 – P. 81-88.

13. Igweh J.C. The effects of menopause on the serum lipid profile of normal females of South East Nigeria / J.C. Igweh, I.U. Nwagha, J.M. Okaro // Niger J Physiol Sci. – 2005. – Vol. 20, №1. – Р. 48-53.

14. Jacobs A.K. Coronary revascularization in women 2003. Sex revisited / A.K. Jacobs // Circulation. – 2003. – Vol.107. – P. 375-377.

15. Kannel W.B. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study / W.B. Kannel // Am Heart J. – 1987. – Vol. 114, №2. – Р. 413-422.

16. Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN study) clinical trial / L.H. Kuller, L.S. Kinzel, K.K. Pettee [et al.] // J Womens Health. – 2006. – Vol. 15, №8. – Р. 962-974.

17. Luboshitzky R. Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism / R. Luboshitzky, P. Herer // Neuro Endocrinol Lett. – 2004. – Vol. 25, №4. – Р. 262-268.

18. Montalcini T. Endogenous testosterone and endothelial function in postmenopausal women / T. Montalcini, G. Gorgone, C. Gazzaruso // Coron Artery Dis. – 2007. – Vol. 18, №1. – Р. 9-13.

19. Nielsen N. E. Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics / N. E. Nielsen, A. G. Olsson, E. Swahn // Journal of Internal Medicine. – 2000. – Vol. 247. – Р. 43-52.

20. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial / Rossouw J.E., Anderson G.L., Prentice R.L. [et al.] // JAMA. – 2002. – Vol. 288. – P. 321–333.

21. Rosano G.M. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system / G.M. Rosano, C. Vitale, M. Fini // Ann N Y Acad Sci. – 2006. – Vol. 1092. – Р. 341-348.

22. Rossouw J.E. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease / J.E. Rossouw // Ann N Y Acad Sci. – 2006. – Vol. 1089. – Р. 444-453.

23. Serum sex hormones in premenopausal women with coronary heart disease / M.J. Mohamad, M.Karayyem, M.A.Mohammad [et al.] // Neuro Endocrinol Lett. – 2006. – Vol. 27, №6. – Р. 758-762.

24. Some Thoughts on the Vasculopathy of Women With Ischemic Heart Disease / Carl J. Pepine, Richard A. Kerensky, Charles R. Lambert [et al.] // Journal of the American College of Cardiology. – 2006. – Vol. 47, №3. – Р. 30-35.

25. The Women’s Health Initiative Steering Committee. Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy: The Women’s Health Initiative Randomized Controlled Trial // JAMA. – 2004. – Vol. 291. – Р. 1701-1712.

26. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation / D’Agostino R.B.Sr, Grundy S., Sullivan L.M. [et al.] // JAMA. – 2001.- Vol. 286. - P. 180–187.

27. Wenger N.K. Coronary heart disease: The female heart is vulnerable / N.K. Wenger // Prog Cardiovasc Dis. – 2003. – Vol. 46. – P. 199-229.

28. Wenger N.K. Menopausal hormone therapy and cardiovascular disease / N.K. Wenger // Rev Esp Cardiol. – 2006. – Vol. 59, №10. – P. 1058-1069.

Thank you very much Iryna